NCT02280603View on ClinicalTrials.gov

Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Androgenetic Alopecia
Interventions
DRUG

DA-4001C

1ml by topical application twice a day

DRUG

5% minoxidil

1ml by topical application twice a day

Trial Locations (1)

130-709

Catholic Medical Center, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02280603 - Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application | Biotech Hunter | Biotech Hunter